Mirae Asset Global Investments
CLDX icon

Mirae Asset Global Investments’s Celldex Therapeutics CLDX Stock Holding History

Mirae Asset Global Investments’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,779
Closed -$938K – 1719
2024
Q1 		$938K Sell
25,779
-479
-2% -$19.7K ﹤0.01% 1575
2023
Q4 		$1.04M Buy
26,258
+962
+4% +$28.3K ﹤0.01% 1598
2023
Q3 		$696K Sell
25,296
-1,730
-6% -$54.2K ﹤0.01% 1722
2023
Q2 		$922K Buy
27,026
+1,511
+6% +$50.9K ﹤0.01% 1617
2023
Q1 		$918K Buy
25,515
+5,986
+31% +$258K ﹤0.01% 1593
2022
Q4 		$870K Hold
19,529
– – ﹤0.01% 1572
2022
Q3 		$549K Buy
19,529
+5,780
+42% +$177K ﹤0.01% 1817
2022
Q2 		$371K Buy
+13,749
New +$399K ﹤0.01% 1888

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return